Novel window for cancer nanotheranostics: non-invasive ocular assessments of tumor growth and nanotherapeutic treatment efficacy in vivo
- 11 December 2018
- journal article
- research article
- Published by Optica Publishing Group in Biomedical Optics Express
- Vol. 10 (1) , 151-166
Abstract
In cancer research there is a fundamental need for animal models that allow the in vivo longitudinal visualization and quantification of tumor development, nanotherapeutic delivery, the tumor microenvironment including blood vessels, macrophages, fibroblasts, immune cells, and extracellular matrix, and the tissue response to treatment. To address this need, we developed a novel mouse ocular xenograft model. Green fluorescent protein (GFP) expressing human glioblastoma cells (between 500 and 10,000) were implanted into the subretinal space of immunodeficient mice (56 eyes). The resultant xenografts were imaged in vivo non-invasively with combined fluorescence scanning laser ophthalmoscopy (SLO) and volumetric optical coherence tomography (OCT) for a period up to several months. Most xenografts exhibited a latent phase followed by a stable or rapidly increasing volume, but about 1/3 underwent spontaneous remission. After prescribed growth, a population of tumors was treated with intravenously delivered doxorubicin-containing porphyrin and cholic acid-based nanoparticles (“nanodox”). Fluorescence resonance energy transfer (FRET) emission (doxorubicin → porphyrin) was used to localize nanodox in the xenografts, and 690 nm light exposure to activate it. Such photo-nanotherapy was highly effective in reducing tumor volume. Histopathology and flow cytometry revealed CD4 + and CD8 + immune cell infiltration of xenografts. Overall, the ocular model shows potential for examining the relationships between neoplastic growth, neovascularization and other features of the immune microenvironment, and for evaluating treatment response longitudinally in vivo.Keywords
Funding Information
- National Institutes of Health (NIH) (5P30 EY012576, R01 EY01256, R01 EY026556, U01 CA198880)
- UC Davis Comprehensive Cancer Center
This publication has 44 references indexed in Scilit:
- Orbital positron emission tomography/computed tomography (PET/CT) imaging findings in graves ophthalmopathyBMC Research Notes, 2013
- Optical imaging of the chorioretinal vasculature in the living human eyeProceedings of the National Academy of Sciences, 2013
- Ophthalmologic abnormalities on FDG-PET/CT: a pictorial essayCancer Imaging, 2013
- The treatment of glioblastoma multiforme through activation of microglia and TRAIL induced by rAAV2-mediated IL-12 in a syngeneic rat modelJournal of Biomedical Science, 2012
- Imaging single cells in the living retinaVision Research, 2011
- In vivo volumetric imaging of human retinal circulation with phase-variance optical coherence tomographyBiomedical Optics Express, 2011
- Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In MicePLOS ONE, 2010
- Intravital imaging of metastatic behavior through a mammary imaging windowNature Methods, 2008
- Adaptation of a support vector machine algorithm for segmentation and visualization of retinal structures in volumetric optical coherence tomography data setsJournal of Biomedical Optics, 2007
- The scanning laser ophthalmoscope—a review of its role in bioscience and medicinePhysics in Medicine & Biology, 2004